| Mr Terrence Joseph Jatczak, NP-C | |
|
300 S Byron Blvd, Chamberlain, SD 57325-9741 | |
| (605) 234-5511 | |
| Not Available |
| Full Name | Mr Terrence Joseph Jatczak |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 300 S Byron Blvd, Chamberlain, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700330461 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | CP001195 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Chamberlain Medical Center | Chamberlain, SD | Hospital |
| Huron Regional Medical Center | Huron, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Health Network | 6800707100 | 272 |
News Archive
People who have experienced childhood trauma get a more pleasurable "high" from morphine, new research suggests.
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's annual meeting being held in Vienna, Austria from March 3 - 7, 2011.
In a study published in the journal Antiviral Research, researchers from Aarhus University, Denmark, report on their tests on different polyether ionophores to inhibit SARS-CoV-2 in vitro.
MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.
Ten health care innovations, if brought to scale immediately in low-resource countries, could have the potential to save the lives of some 1.2 million mothers and children in 2015.
› Verified 8 days ago
| Entity Name | Sanford Health Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790721280 PECOS PAC ID: 6800707100 Enrollment ID: O20031111000266 |
News Archive
People who have experienced childhood trauma get a more pleasurable "high" from morphine, new research suggests.
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's annual meeting being held in Vienna, Austria from March 3 - 7, 2011.
In a study published in the journal Antiviral Research, researchers from Aarhus University, Denmark, report on their tests on different polyether ionophores to inhibit SARS-CoV-2 in vitro.
MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.
Ten health care innovations, if brought to scale immediately in low-resource countries, could have the potential to save the lives of some 1.2 million mothers and children in 2015.
› Verified 8 days ago
| Entity Name | Sanford Health Network |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1134140825 PECOS PAC ID: 6800707100 Enrollment ID: O20061104000503 |
News Archive
People who have experienced childhood trauma get a more pleasurable "high" from morphine, new research suggests.
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's annual meeting being held in Vienna, Austria from March 3 - 7, 2011.
In a study published in the journal Antiviral Research, researchers from Aarhus University, Denmark, report on their tests on different polyether ionophores to inhibit SARS-CoV-2 in vitro.
MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.
Ten health care innovations, if brought to scale immediately in low-resource countries, could have the potential to save the lives of some 1.2 million mothers and children in 2015.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Terrence Joseph Jatczak, NP-C 300 S Byron Blvd, Chamberlain, SD 57325-9741 Ph: (605) 234-5511 | Mr Terrence Joseph Jatczak, NP-C 300 S Byron Blvd, Chamberlain, SD 57325-9741 Ph: (605) 234-5511 |
News Archive
People who have experienced childhood trauma get a more pleasurable "high" from morphine, new research suggests.
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's annual meeting being held in Vienna, Austria from March 3 - 7, 2011.
In a study published in the journal Antiviral Research, researchers from Aarhus University, Denmark, report on their tests on different polyether ionophores to inhibit SARS-CoV-2 in vitro.
MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded as part of the Affordable Care Act, apply to small-company R&D expenditures that reduce the cost and increase the quality of healthcare in the U.S. The grants will be applied to the development of MicroPhage's first product, the MRSA/MSSA Blood Culture Test, currently under review at the FDA.
Ten health care innovations, if brought to scale immediately in low-resource countries, could have the potential to save the lives of some 1.2 million mothers and children in 2015.
› Verified 8 days ago
Carmen Hendrix, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-234-6551 | |
Sara Kay Klein, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 101 South Front St., Chamberlain, SD 57325 Phone: 605-234-5684 Fax: 605-234-5002 | |
Debra K Webb, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-234-6551 Fax: 605-234-7260 | |
Tonya L Struble, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-234-6551 Fax: 605-234-7260 | |
Kasey J Hanson, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-337-3364 Fax: 605-337-3360 | |
Kala M Shepherd, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-234-6551 Fax: 605-234-7260 |